Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
U-CH1
Cat.No.: CSC-C9258W
Species: Human
Source: sacral bone
Morphology: mesenchymal like
- Specification
- Q & A
- Customer Review
Stringent record-keeping, authentication at receipt and before use, and implementation of cell line-specific protocols help minimize the risk of misidentification and cross-contamination.
Ask a Question
Average Rating: 4.0 | 1 Scientist has reviewed this product
Studying tumor heterogeneity
The cells encompass a diverse range of subpopulations, making it possible to investigate various aspects of tumor heterogeneity easily. I found the product to be a reliable tool for unraveling the intricacies of tumor evolution.
09 Feb 2023
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: Established from the primary lesion resected from a 76-year-old woman with bulky, moderately differentiated squamous cell carcinoma of the vulva in 1984; cells were reported to express an elevated number of high affinity EGF receptors, to carry gene amplification at 11q13 and to be tumorigenic in nude mice
Description: Established from the solid tumor of a 52-year-old Caucasian man with advanced stage malignant bile duct carcinoma (patient had not received any chemotherapy prior to cell explantation) in 1984 and three consecutive passages in female nu/nu mice (NMRI); primary tumor histology: large cell adenocarcinoma of low differentiation, metastasizing (ascites in patient); human character of cell line confirmed by karyotype in passage #34 of in vitro culture (1986)
Description: Subclone of ACH1P which was established by fusion of the JEG-3-derived HGPRT-defective mutant cell line AC1-1 with primary male trophoblast cells isolated from term human chorion laeve; described as possessing both, a distinct karyotype and a distinct expression pattern of tumor-related genes
Description: One of five phenotypically and cytogenetically distinct subclones of a hybrid (ACH1P) formed by fusing an HGPRT-defective mutant (AC1-1) of JEG-3 human choriocarcinoma with primary human trophoblast (chorion laeve) cells
Description: Established by somatic hybridization of primary male trophoblast cells and the HGPRT-defective choriocarcinoma cell line AC1-1 which was originally derived from cell line JEG-3
Description: NTERA-2 was cloned from cell line TERA-2 which was derived from a metastatic teratocarcinoma of a 22-year-old Caucasian male; cell line also known as NT-2
